髓状细胞恶性瘤中的血栓形成:从CHIP到AML
Beatrice Borsellino1, Carlos Bravo-Perez2,3, Valeria Visconte2
1Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, 00133, Italy.
Cardiovascular & hematological disorders drug targets
|June 16, 2024
概括
克隆性血液形成 (CHIP) 是骨髓质恶性瘤的前体,增加了凝血风险. 本综述检查了髓状细胞癌发育中的血栓形成,从CHIP到急性髓状细胞白血病 (AML).
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 血栓形成研究研究
背景情况:
- 骨髓瘤恶性瘤从前恶性阶段逐渐发展,例如不确定潜力的克隆性血液形成 (CHIP).
- CHIP是已知的血液癌症 (例如,骨髓质疏松综合征,急性骨髓性白血病) 和心血管事件的风险因素.
- 血栓并发症越来越多地被认为是髓状瘤恶性病的重要问题.
研究的目的:
- 综合审查骨髓性恶性瘤中血栓形成的发病率,病变发生和临床影响.
- 巩固从CHIP到急性髓性白血病 (AML) 的恶性进展谱的证据.
主要方法:
- 关于CHIP,骨髓瘤恶性瘤和血栓形成的研究文献综述.
- 综合有关血栓风险因素和受影响患者的结局的数据.
主要成果:
- CHIP与血液恶性瘤和血栓事件的风险增加有关.
- 血栓形成是一个相关的临床问题,在整个髓状腺癌的进展过程中.
- 目前有证据表明,特定的分子驱动因子与骨髓性恶性瘤中的血栓形成有关.
结论:
- 了解骨髓性恶性瘤中的血栓形成对于患者管理至关重要.
- 需要进一步的研究来阐明机制,并制定有针对性的预防策略.
- 解决血栓风险对于改善骨髓瘤恶性瘤患者的治疗结果至关重要.
关键词:
血栓形成的原因之一是血栓形成.维克萨斯综合征 (VEXAS综合征) 是一种急性骨髓性白血病 (AML) 是一种急性骨髓性白血病.急性前列腺细胞白血病.不确定的潜在的克隆性血液形成.骨髓发育不良综合征更多相关视频
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
14.0K
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
29.3K
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
675
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
675
01:24Disorders of Hemostasis
831
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
831